A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design-Reference-Cited by-同舟云学术

A Combined Nucleic Acid and Protein Analysis in Friedreich Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design

Published:2011-03-11 Issue:3 Volume:6 Page:e17627
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Saccà Francesco,Puorro Giorgia,Antenora Antonella,Marsili Angela,Denaro Alessandra,Piro Raffaele,Sorrentino Pierpaolo,Pane Chiara,Tessa Alessandra,Brescia Morra Vincenzo,Cocozza Sergio,De Michele Giuseppe,Santorelli Filippo M.,Filla Alessandro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Friedreich's ataxia: a clinical and genetic stud of 90 families with analysis of early diagnostic criteria and intrafamilial clustering of clinical features.;AE Harding;Brain,1981

2. Accuracy of clinical diagnostic criteria for Friedreich's ataxia.;A Filla;Mov Disord,2000

3. Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients.;G De Michele;Neurology;,1996

4. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.;V Campuzano;Science,1996

5. Real Time PCR quantification of frataxin mRNA in the peripheral blood leukocytes of Friedreich's ataxia patients and carriers.;L Pianese;J Neurol Neurosurg Psychiatry,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New and Emerging Drug and Gene Therapies for Friedreich Ataxia;CNS Drugs;2024-08-08

2. Anatomical and functional analysis of the corticospinal tract in an FRDA mouse model;2024-07-02

3. Loss of filamentous actin, tight junction protein expression, and paracellular barrier integrity in frataxin-deficient human brain microvascular endothelial cells—implications for blood-brain barrier physiology in Friedreich’s ataxia;Frontiers in Molecular Biosciences;2024-01-11

4. Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application;Translational Neurodegeneration;2023-09-20

5. Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201);Frontiers in Neuroscience;2023-09-07